Avezum A - Search Results

1

Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.

Mehta SR, Boden WE, Eikelboom JW, Flather M, Steg PG, Avezum A, Afzal R, Piegas LS, Faxon DP, Widimsky P, Budaj A, Chrolavicius S, Rupprecht HJ, Jolly S, Granger CB, Fox KA, Bassand JP, Yusuf S; OASIS 5 and 6 Investigators. Mehta SR, et al. Among authors: avezum a. Circulation. 2008 Nov 11;118(20):2038-46. doi: 10.1161/CIRCULATIONAHA.108.789479. Epub 2008 Oct 27. Circulation. 2008. PMID: 18955665 Clinical Trial.

2

Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE).

Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, López-Sendón J; GRACE Investigators. Eagle KA, et al. Among authors: avezum a. Lancet. 2002 Feb 2;359(9304):373-7. doi: 10.1016/S0140-6736(02)07595-5. Lancet. 2002. PMID: 11844506

3

Extent of, and factors associated with, delay to hospital presentation in patients with acute coronary disease (the GRACE registry).

Goldberg RJ, Steg PG, Sadiq I, Granger CB, Jackson EA, Budaj A, Brieger D, Avezum A, Goodman S. Goldberg RJ, et al. Among authors: avezum a. Am J Cardiol. 2002 Apr 1;89(7):791-6. doi: 10.1016/s0002-9149(02)02186-0. Am J Cardiol. 2002. PMID: 11909560

4

Risk factors for myocardial infarction in Brazil.

Piegas LS, Avezum A, Pereira JC, Neto JM, Hoepfner C, Farran JA, Ramos RF, Timerman A, Esteves JP; AFIRMAR Study Investigators. Piegas LS, et al. Among authors: avezum a. Am Heart J. 2003 Aug;146(2):331-8. doi: 10.1016/S0002-8703(03)00181-9. Am Heart J. 2003. PMID: 12891204

5

Predictors of hospital mortality in the global registry of acute coronary events.

Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van De Werf F, Avezum A, Goodman SG, Flather MD, Fox KA; Global Registry of Acute Coronary Events Investigators. Granger CB, et al. Among authors: avezum a. Arch Intern Med. 2003 Oct 27;163(19):2345-53. doi: 10.1001/archinte.163.19.2345. Arch Intern Med. 2003. PMID: 14581255

6

Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE).

Budaj A, Brieger D, Steg PG, Goodman SG, Dabbous OH, Fox KA, Avezum A, Cannon CP, Mazurek T, Flather MD, Van De Werf F; GRACE Investigators. Budaj A, et al. Among authors: avezum a. Am Heart J. 2003 Dec;146(6):999-1006. doi: 10.1016/S0002-8703(03)00509-X. Am Heart J. 2003. PMID: 14660991

7

Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction.

Mehta RH, Sadiq I, Goldberg RJ, Gore JM, Avezum A, Spencer F, Kline-Rogers E, Allegrone J, Pieper K, Fox KA, Eagle KA; GRACE Investigators. Mehta RH, et al. Among authors: avezum a. Am Heart J. 2004 Feb;147(2):253-9. doi: 10.1016/j.ahj.2003.08.007. Am Heart J. 2004. PMID: 14760322

8

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA; GRACE Investigators. Eagle KA, et al. Among authors: avezum a. JAMA. 2004 Jun 9;291(22):2727-33. doi: 10.1001/jama.291.22.2727. JAMA. 2004. PMID: 15187054

9

Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.

Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG. Eagle KA, et al. Among authors: avezum a. Am J Med. 2004 Jul 15;117(2):73-81. doi: 10.1016/j.amjmed.2003.12.041. Am J Med. 2004. PMID: 15234641

10

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L; INTERHEART Study Investigators. Yusuf S, et al. Among authors: avezum a. Lancet. 2004 Sep 11-17;364(9438):937-52. doi: 10.1016/S0140-6736(04)17018-9. Lancet. 2004. PMID: 15364185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page